← All trials
NCT05050279
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 29, 2021
- Primary completion
- Nov 24, 2021
- Completion date
- Dec 4, 2021
- First posted
- Sep 20, 2021
- Last posted
- Oct 11, 2021
- Enrollment
- 40
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Leo PharmaLead sponsor
- Leo PharmaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.